37722-82-0

Basic information

• Product Name: Methyl 3-hydroxycyclohexanecarboxylate
• Synonyms: Methyl 3-hydroxycyclohexanecarboxylate;Cyclohexanecarboxylic acid, 3-hydroxy-, Methyl ester;Methyl 3-hydroxycyclohexane-1-carboxylate
• CAS NO: 37722-82-0
• Molecular Formula: C₈H₁₄O₃
• Molecular Weight: 158
• Mol File: 37722-82-0.mol

Chemical Properties

• Boiling Point: 95 °C(Press: 1.1 Torr)
• Appearance: /
• Density: 1.121±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 14.90±0.40(Predicted)
• CAS DataBase Reference: Methyl 3-hydroxycyclohexanecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 3-hydroxycyclohexanecarboxylate(37722-82-0)
• EPA Substance Registry System: Methyl 3-hydroxycyclohexanecarboxylate(37722-82-0)

Safety Data

• Hazardous Substances Data: 37722-82-0(Hazardous Substances Data)

Usage

Uses

Used in Fragrance and Flavor Industry:
Methyl 3-hydroxycyclohexanecarboxylate is used as a key ingredient in the fragrance and flavor industry for its pleasant and fruity scent. It adds a unique aroma to various products, enhancing their appeal to consumers.
Used in Pharmaceutical Industry:
Methyl 3-hydroxycyclohexanecarboxylate has potential applications in the pharmaceutical industry. Its properties may contribute to the development of new drugs or improve the effectiveness of existing ones. However, further research is needed to fully explore its potential in this field.
Used in Cosmetic Industry:
In the cosmetic industry, Methyl 3-hydroxycyclohexanecarboxylate can be used as a fragrance or flavoring agent in various cosmetic products. Its pleasant odor makes it suitable for use in products such as perfumes, body lotions, and other personal care items.
Safety:
Methyl 3-hydroxycyclohexanecarboxylate is considered to have low toxicity and is generally regarded as safe for use in consumer products when appropriately formulated and used. This makes it a preferred choice for industries that prioritize the safety and well-being of their customers.

Upstream product

• 67-56-1 methanol 
• 606488-94-2 3-hydroxycyclohexane-1-carboxylic acid 
• 21531-44-2 (+/-)-trans-3-hydroxycyclohexanecarboxylic acid 
• 17983-30-1 (RS)-3-oxocyclohexanecarbonitrile 
• 4350-83-8 6-oxa-bicyclo[3.2.1]octan-7-one 
• 99799-10-7 3-methoxy-1-cyclohexanecarboxylic acid 
• 124-41-4 sodium methylate 
• 4350-83-8 6-oxabicyclo[3.2.1]octan-7-one 
• 99407-64-4 (+/-)-methyl 3,3-dimethoxycyclohexanecarboxylate 
• 21531-47-5 3-oxo-cyclohexanecarboxylic acid methyl ester 
• 186581-53-3 diazomethane 
• 21531-44-2 (+/-)-cis-3-hydroxycyclohexanecarboxylic acid 
• 19438-10-9 methyl 3-hydroxybenzoate 
• 16205-98-4 3-oxo-cyclohexanecarboxylic acid 

Downstream Products

• 21531-47-5 3-oxo-cyclohexanecarboxylic acid methyl ester 
• 33668-25-6 ethyl 3-oxocyclohexanecarboxylate 
• 70144-91-1 methyl (1R,3S)-3-hydroxycyclohexane-1-carboxylate 
• 149055-86-7 methyl (1S,3R)-3-hydroxycyclohexane-1-carboxylate 
• 99438-47-8 methyl (1S,3S)-3-hydroxycyclohexane-1-carboxylate 
• 15753-48-7 (+/-)-trans-3-(hydroxymethyl)cyclohexanol 
• 15753-48-7 (+/-)-cis-3-(hydroxymethyl)cyclohexanol 
• 6125-56-0 (3S)-3-hydroxycyclohexane-1-carboxylic acid methyl ester 
• 6125-56-0 (+/-)-methyl cis-3-hydroxycyclohexanecarboxylate 
• 102437-55-8 5-carbomethoxy-2-trans-(3-hydroxypropyl)cyclohexanol 
• 102437-44-5 2-Allyl-3-oxo-cyclohexanecarboxylic acid methyl ester 
• 102437-56-9 methyl 4-allyl-3-(tosyloxy)cyclohexanecarboxylate 
• 102437-57-0 methyl 4-(3-hydroxypropyl)-3-(tosyloxy)cyclohexanecarboxylate 
• 102437-53-6 5-carbomethoxy-2-cis-allylcyclohexanol 

Relevant articles and documents

DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES

Provided herein are dihydropyrimidine derivatives which are useful in the treatment of HBV infection or HBV-induced diseases, as well as pharmaceutical or medical applications thereof.

Glutaminase inhibitors as well as compositions and applications thereof

The invention provides a series of heterocyclic compounds expressed in a formula I. The compound comprises glutaminase inhibition activity, and can be used for treating diseases and symptoms related to dysfunction of glutaminase or raising activity of glutaminase.

SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT

The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.

TRPV4 ANTAGONISTS

The present invention relates to spirocarbamate analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.

NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS

Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK- activated protein kinase. The compounds of the present invention are useful in

1- (1-CYCLOHEXYL-4-PIPERIDINYL) -1, 3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES WHICH HAVE ACTIVITY ON THE M1 RECEPTOR AND THEIR USE IN MEDICINE

Compounds of formula (I) or a salt thereof are provided, wherein R4, R5, R6, Q and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders and cognitive impairments are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.

METHOD FOR THE PREPARATION OF ENANTIOMER FORMS OF CIS-CONFIGURED 3-HYDROXYCYCLOHEXANE CARBOXYLIC ACID DERIVATIVES USING HYDROLASES

The present invention relates to a process for preparing chiral non-racemic cis-configured cyclohexanols or cyclohexanol derivatives of the formula (I) Cis-configured hydroxyl-cyclohexane carboxylic acid derivatives of formula (I) are central building blo

General Syntheses of 6- and 7-Carbomethoxy-trans-1-heteradecalins and 6- and 7-Carbomethoxy-trans-2-heteradecalins

Two routes to all of the title compounds in the oxa and aza series have been studied.The most general path, involving a cyclohexene oxide intermediate, was not successful becauase of difficulty in separating regioisomers.Allylation of 4-carbomethoxycyclohexanone (11) followed by reduction produced the required trans-disubstituted allyl alcohols, which were converted to all of the desired 6-carbomethoxy-trans-1-heteradecalins.The allyl ketones were subjected to a homologation-side chain contraction sequence to produce the 6-carbomethoxy-trans-2-heteradecalins.Allylation of 3-carbomethoxycyclohexanone (12) was not regioselective, but all four product isomers were characterized.The desired 5-carbomethoxy-2-allylcyclohexanone isomers (27 and 28) were converted to the 7-carbomethoxy-trans-decalins by similar series of reactions

Enzymatic in vitro Reduction of Ketones. Part 13. Horse Liver Alcohol Dehydrogenase (HLAD) as a Tool for the Synthesis of Enantiomerically Pure Alkyl 3-oxo- and 3-hydroxycyclohexanecarboxylates.

Enantiomerically pure alkyl 3-oxocyclohexanecarboxylates and the corresponding alcohols have been prepared using HLAD as a suitable catalyst.Kinetic and thermodynamic parameters for the enzymatic reductions are given.The enantiomeric purity and the absolute configuration of the reaction products are determined.The alcohol moiety (methyl, isopropyl or pentyl) of the ester group influences both the steric course and the kinetics of the reduction.Side reactions of the substrate with the reaction medium can be avoided by an appropriate choice of the reaction conditions.